Drug intelligence / Profile preview

donepezil

Development stage
Approved
Lead developer
Eisai
Modality
Small Molecules
Administration
Oral, Transdermal
01

Overview

Donepezil is a small molecule pharmaceutical drug classified as a cholinesterase inhibitor. It is primarily used to treat dementia associated with Alzheimer's disease, including mild, moderate, and severe stages. Donepezil works by reversibly inhibiting acetylcholinesterase in the brain, thereby increasing acetylcholine concentrations at cholinergic synapses and improving cognitive function such as memory and attention. In addition to its main mechanism of action on acetylcholinesterase, donepezil also acts as an agonist of the sigma-1 receptor and may upregulate nicotinic receptors in cortical neurons. While it can improve symptoms or slow their progression in Alzheimer's disease patients, it does not cure the underlying condition or halt its eventual progression[1][3][5][6][8].

Brand names
AriceptAricept ODTAdlarity
Other names
donepezil hydrochloride
02

Targets

SIGMAR1 (Sigma non-opioid intracellular receptor 1)Acetylcholinesterase

Beyond the preview

Go deeper on donepezil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on donepezil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call